News

Filter

Current filters:

Actelion

1 to 9 of 83 results

Strong data on Actelion’s Uptravi presented at ACC 2015

16-03-2015

Swiss biotech firm Actelion yesterday presented much anticipated positive key long-term outcome data…

ActelionBiotechnologyResearchRespiratory and PulmonaryselexipagUptravi

FDA formally accepts Actelion's NDA for Uptravi

FDA formally accepts Actelion's NDA for Uptravi

04-03-2015

Switzerland-based Actelion, Europe’s largest biotech company, says that the US Food and Drug Administration…

ActelionBiotechnologyRegulationRespiratory and PulmonaryselexipagUptraviUSA

Actelion posts strong 2014 earnings growth, but sales shy of expectations

Actelion posts strong 2014 earnings growth, but sales shy of expectations

16-02-2015

Switzerland-based Actelion this morning reported financial results for full-year 2014, showing that sales…

ActelionBiotechnologyFinancialRespiratory and Pulmonary

Actelion submits New Drug Application to the FDA for pulmonary arterial hypertension drug Uptravi

Actelion submits New Drug Application to the FDA for pulmonary arterial hypertension drug Uptravi

23-12-2014

Swiss biotech company Actelion has submitted a New Drug Application to the US Food and Drug Administration…

ActelionCardio-vascularPharmaceuticalRegulationselexipagSwitzerland

Actelion submits selexipag for EMA marketing authorization in PAH

Actelion submits selexipag for EMA marketing authorization in PAH

03-12-2014

Swiss biotech firm Actelion has submitted a centralized Marketing Authorization Application to the European…

ActelionCardio-vascularEuropePharmaceuticalRegulationselexipag

Actelion beats expectations as third-qtr net profit rockets 39%

Actelion beats expectations as third-qtr net profit rockets 39%

21-10-2014

Switzerland’s Actelion, Europe’s largest biotech company, this morning announced third-quarter 2014…

ActelionBiotechnologyFinancialOpsumitRespiratory and PulmonarySwitzerlandTracleer

Genzyme’s Cerdelga gets FDA approval for Gaucher disease

Genzyme’s Cerdelga gets FDA approval for Gaucher disease

20-08-2014

The US Food and Drug Administration late yesterday approved Cerdelga (eliglustat) for the long-term treatment…

ActelionBiotechnologyCerdelgaCerezymeGenzymeRare diseasesRegulationSanofiUSAZavesca

PatientsLikeMe and Actelion to collaborate on new tool for non-Hodgkin’s lymphoma patients

PatientsLikeMe and Actelion to collaborate on new tool for non-Hodgkin’s lymphoma patients

06-08-2014

Swiss biotech firm Actelion is to partner with patient-powered research network PatientsLikeMe to create…

ActelionMitchell NagaoOncologyPatientsLikeMePharmaceuticalResearchSwitzerland

1 to 9 of 83 results

Back to top